Strensiq

Active Ingredient(s): Asfotase Alfa
FDA Approved: * October 23, 2015
Pharm Company: * ALEXION PHARM

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Recent Strensiq Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Asfotase Alfa
  • Solution: 18mg/0.45ml, 28mg/0.7ml, 40mg/ml, 80mg/0.8ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Strensiq: (4 results)

Sorted by National Drug Code
  • 25682-010 Strensiq 18 mg/.45ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.
  • 25682-013 Strensiq 28 mg/.7ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.
  • 25682-016 Strensiq 40 mg/ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.
  • 25682-019 Strensiq 80 mg/.8ml Subcutaneous Solution by Alexion Pharmaceuticals Inc.

Other drugs which contain Asfotase Alfa or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA